SCHEMBL17975241

SCHEMBL17975241

CC(=O)n1c(P(C(C)(C)C)C(C)(C)C)nc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ POLB P06746 1/20 0.43
▸ CNR2 P34972 2/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ PKM P14618 2/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ SLC22A12 Q96S37 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16586347 0.81 LMNA (0.48) CYP1A2CYP3A4CYP2D6L3MBTL1KMT2A
SCHEMBL17975237 0.79 CYP1A2 (0.51) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL17975232 0.78 KMT2A (0.48) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL17975235 0.78 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL30306278 0.78 CNR2 (0.62) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL822015 0.75 ALDH1A1 (0.68) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL17960688 0.75 SMN1; SMN2 (0.53) NPC1RAB9AL3MBTL1KMT2AALDH1A1
SCHEMBL9486088 0.73 NPC1 (0.51) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL21809122 0.73 CYP2C9 (0.52) CYP1A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL17975238 0.73 SMN1; SMN2 (0.47) CYP1A2CYP3A4CYP2D6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222042-A1 NOVEL PHOSPHINES, SYNTHESIS THEREOF AND THEIR USE IN CATALYSIS THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2016-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160222042-A1 NOVEL PHOSPHINES, SYNTHESIS THEREOF AND THEIR USE IN CATALYSIS PHOSPHO1, PPIP5K2, PDXK CYP1A2 3343/4885CYP3A4 1558/4885CYP2D6 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback